You just read:

Araim Pharmaceuticals announces a strategic partnership with Vault Bioventures to support development and commercialization of ARA 290 as well as other peptides within a novel family

News provided by

Araim Pharmaceuticals, Inc.

Dec 31, 2015, 10:42 ET